<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7203261\results\search\disease\results.xml">
  <result pre="we learned http://orcid.org/0000-0001-7132-000XProvenzaniAlessioaprovenzani@ismett.eduPolidoriPiera[], grid.419663.f0000 0001 2110 1693Department of Clinical Pharmacy," exact="Mediterranean" post="Institute for Transplantation and Advanced Specialized Therapies (ISMETT), epub:"/>
  <result pre="2110 1693Department of Clinical Pharmacy, Mediterranean Institute for Transplantation and" exact="Advanced" post="Specialized Therapies (ISMETT), epub: 2020-5-514received: 2020-3-17accepted: 2020-4-27(C) , This"/>
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="declaration of COVID-19 as a global pandemic. Abstract COVID-19, the" exact="disease" post="associated in December 2019 with the novel coronavirus SARS-CoV-2,"/>
  <result pre="still no licensed specific antiviral treatment for the human coronavirus" exact="disease" post="and a vaccine will not be ready soon. However,"/>
  <result pre="treatment Coronavirus COVID-19 SARS-CoV-2 Since 31 December 2019, COVID-19, the" exact="disease" post="associated with the novel coranovirus Severe Acute Respiratory Syndrome"/>
  <result pre="December 2019, COVID-19, the disease associated with the novel coranovirus" exact="Severe" post="Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), caused so far thousands"/>
  <result pre="2019, COVID-19, the disease associated with the novel coranovirus Severe" exact="Acute" post="Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), caused so far thousands of"/>
  <result pre="COVID-19, the disease associated with the novel coranovirus Severe Acute" exact="Respiratory" post="Syndrome Coronavirus-2 (SARS-CoV-2), caused so far thousands of confirmed"/>
  <result pre="the disease associated with the novel coranovirus Severe Acute Respiratory" exact="Syndrome" post="Coronavirus-2 (SARS-CoV-2), caused so far thousands of confirmed cases"/>
  <result pre="outbreak, but officially a pandemic [2, 3]. COVID-19, like the" exact="Severe" post="Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome"/>
  <result pre="but officially a pandemic [2, 3]. COVID-19, like the Severe" exact="Acute" post="Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS),"/>
  <result pre="officially a pandemic [2, 3]. COVID-19, like the Severe Acute" exact="Respiratory" post="Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), belongs"/>
  <result pre="a pandemic [2, 3]. COVID-19, like the Severe Acute Respiratory" exact="Syndrome" post="(SARS) and Middle East Respiratory Syndrome (MERS), belongs to"/>
  <result pre="like the Severe Acute Respiratory Syndrome (SARS) and Middle East" exact="Respiratory" post="Syndrome (MERS), belongs to the group of ribonucleic acid"/>
  <result pre="the Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory" exact="Syndrome" post="(MERS), belongs to the group of ribonucleic acid (RNA)"/>
  <result pre="still no licensed specific antiviral treatment for the human coronavirus" exact="disease" post="and a vaccine will not be ready soon. Treatment"/>
  <result pre="ribavirin was initially considered a promising therapy for treating COVID-19" exact="infections" post="[10, 11], a recent study comparing a group of"/>
  <result pre="study had several limitations, one of all the lack of" exact="blindness" post="and inhomogeneity of the arms with respect to some"/>
  <result pre="to some patients characteristics such as the severity of the" exact="disease" post="and the onset of baseline symptoms [12]. The results"/>
  <result pre="The results of this study are therefore not transferable to" exact="stable" post="patients and with less serious clinical symptoms. Other authors"/>
  <result pre="Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-induced" exact="Pneumonia" post="[14] included as useful therapy, together with the antimalarial"/>
  <result pre="agent Ribavirin, a guanosine analogue used to treat several virus" exact="infections" post="like hepatitis C virus, respiratory syncytial virus and viral"/>
  <result pre="a guanosine analogue used to treat several virus infections like" exact="hepatitis C" post="virus, respiratory syncytial virus and viral hemorrhagic fevers. However,"/>
  <result pre="used to treat several virus infections like hepatitis C virus," exact="respiratory" post="syncytial virus and viral hemorrhagic fevers. However, for its"/>
  <result pre="virus infections like hepatitis C virus, respiratory syncytial virus and" exact="viral" post="hemorrhagic fevers. However, for its undesiderable side effect like"/>
  <result pre="also by adding the antibacterial drug azithromycin is efficient in" exact="viral" post="load reduction/disappearance [16]. Hydroxychloroquine and chloroquine's antiviral activity appears"/>
  <result pre="activity in vitro, with a single dose able to stop" exact="viral" post="growth in 48Â h [22]. This effect can be"/>
  <result pre="effect can be explained by the inhibition of IMPÎ±/Î²1 during" exact="infection" post="impacting on cell division [22]. So far, researchers have"/>
  <result pre="inhibitor of RNA polymerase, thus determining a premature termination of" exact="viral" post="RNA transcription [10, 13, 26]. Animal experiments showed that"/>
  <result pre="showed that remdesivir in combination with interferon can reduce the" exact="viral" post="load in lung tissue of mice infected with MERS,"/>
  <result pre="COVID-19 [27, 28]. Tocilizumab, a drug approved by FDA for" exact="rheumatoid arthritis" post="and cytokine release syndrome (CRS), seems to be helpful"/>
  <result pre="[27, 28]. Tocilizumab, a drug approved by FDA for rheumatoid" exact="arthritis" post="and cytokine release syndrome (CRS), seems to be helpful"/>
  <result pre="drug approved by FDA for rheumatoid arthritis and cytokine release" exact="syndrome" post="(CRS), seems to be helpful in patients infected with"/>
  <result pre="helpful in patients infected with COVID-19. These patients can develop" exact="uncontrolled" post="immune response leading to serious life-threatening damage to lung"/>
  <result pre="virus, however, inhibiting the interleukin-6 receptor it could decrease theÂ" exact="systemic" post="inflammation (cytokine release storm) and consequently improve the prognosis"/>
  <result pre="Interesting suggestions for future treatments could be the development of" exact="type II" post="transmembrane serine protease (TMPRSS2) inhibitors like camostat mesilate, approved"/>
  <result pre="have some beneficial in patients infected by COVID-19 who experienced" exact="pneumonia" post="[33â€&quot;35]. To the present, there is only one retrospective"/>
  <result pre="is only one retrospective study suggesting that COVID-19 patients with" exact="hypertension" post="and already treated with angiotensin-converting enzyme inhibitors or angiotensin"/>
  <result pre="drugs should ensure better pharmacokinetic properties, greater potency and/or a" exact="lower" post="toxicity profile than currently available therapies. The combined use"/>
  <result pre="pathogenesisJ Med Virol202092441842310.1002/jmv.2568131967327 9.ZhuNZhangDWangWet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med2020382872773310.1056/NEJMoa200101731978945 10.MartinezMACompounds with therapeutic"/>
  <result pre="2019N Engl J Med2020382872773310.1056/NEJMoa200101731978945 10.MartinezMACompounds with therapeutic potential against novel" exact="respiratory" post="2019 coronavirusAntimicrob Agents Chemother202064e0039910.1128/AAC.00399-2032152082 11.ChuCMChengVCHungIFet al.Role of LOPINAVIR/ritonavir in"/>
  <result pre="severe Covid-19N Engl J Med202010.1056/NEJMoa200128232369286 13.DongLHuSGaoJDiscovering drugs to treat coronavirus" exact="disease" post="2019 (COVID-19)Drug Discov Ther2020141586010.5582/ddt.2020.0101232147628 14.https://www.chinalawtranslate.com/coronavirus-treatment-plan-7/?lang=en. Accessed 17 Apr 2020."/>
  <result pre="effects of macrolidesâ€&quot;an underappreciated benefit in the treatment of community-acquired" exact="respiratory" post="tract infections and chronic inflammatory pulmonary conditions?J Antimicrob Chemother2005551102110.1093/jac/dkh51915590715"/>
  <result pre="macrolidesâ€&quot;an underappreciated benefit in the treatment of community-acquired respiratory tract" exact="infections" post="and chronic inflammatory pulmonary conditions?J Antimicrob Chemother2005551102110.1093/jac/dkh51915590715 20.KwiatkowskaBMaÅ›liÅ&quot;skaMMacrolide therapy"/>
  <result pre="benefit in the treatment of community-acquired respiratory tract infections and" exact="chronic" post="inflammatory pulmonary conditions?J Antimicrob Chemother2005551102110.1093/jac/dkh51915590715 20.KwiatkowskaBMaÅ›liÅ&quot;skaMMacrolide therapy in chronic"/>
  <result pre="the treatment of community-acquired respiratory tract infections and chronic inflammatory" exact="pulmonary" post="conditions?J Antimicrob Chemother2005551102110.1093/jac/dkh51915590715 20.KwiatkowskaBMaÅ›liÅ&quot;skaMMacrolide therapy in chronic inflammatory diseasesMediat"/>
  <result pre="and chronic inflammatory pulmonary conditions?J Antimicrob Chemother2005551102110.1093/jac/dkh51915590715 20.KwiatkowskaBMaÅ›liÅ&quot;skaMMacrolide therapy in" exact="chronic" post="inflammatory diseasesMediat Inflamm2012201263615710.1155/2012/636157 21.MolinaJMDelaugerreCGoffJLet al.No evidence of rapid antiviral"/>
  <result pre="Apr 2020. 26.MulanguSDoddLEDaveyRTJret al.A randomized, controlled trial of Ebola virus" exact="disease" post="therapeuticsN Engl J Med2019381242293230310.1056/NEJMoa191099331774950 27.MalikYSSircarSBhatSet al.Emerging novel coronavirus (2019-nCoV)â€&quot;current"/>
  <result pre="scientistsScience2020367647749249310.1126/science.367.6477.49232001631 29.ScottLJTocilizumab: a review in rheumatoid arthritisDrugs201777171865187910.1007/s40265-017-0829-729094311 30.ZhangCWuZLiJWZhaoHWangGQThe cytokine release" exact="syndrome" post="(CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist"/>
  <result pre="J Antimicrob Agents202010.1016/j.ijantimicag.2020.10595432335274 31.GlowackaIBertramSMÃ¼llerMAet al.Evidence that TMPRSS2 activates the severe" exact="acute" post="respiratory syndrome coronavirus spike protein for membrane fusion and"/>
  <result pre="Antimicrob Agents202010.1016/j.ijantimicag.2020.10595432335274 31.GlowackaIBertramSMÃ¼llerMAet al.Evidence that TMPRSS2 activates the severe acute" exact="respiratory" post="syndrome coronavirus spike protein for membrane fusion and reduces"/>
  <result pre="Agents202010.1016/j.ijantimicag.2020.10595432335274 31.GlowackaIBertramSMÃ¼llerMAet al.Evidence that TMPRSS2 activates the severe acute respiratory" exact="syndrome" post="coronavirus spike protein for membrane fusion and reduces viral"/>
  <result pre="respiratory syndrome coronavirus spike protein for membrane fusion and reduces" exact="viral" post="control by the humoral immune responseJ Virol20118594122413410.1128/JVI.02232-1021325420 32.ColemanCMSiskJMMingoRMNelsonEAWhiteJMFriemanMBAbelson kinase"/>
  <result pre="responseJ Virol20118594122413410.1128/JVI.02232-1021325420 32.ColemanCMSiskJMMingoRMNelsonEAWhiteJMFriemanMBAbelson kinase inhibitors are potent inhibitors of severe" exact="acute" post="respiratory syndrome coronavirus and middle east respiratory syndrome coronavirus"/>
  <result pre="Virol20118594122413410.1128/JVI.02232-1021325420 32.ColemanCMSiskJMMingoRMNelsonEAWhiteJMFriemanMBAbelson kinase inhibitors are potent inhibitors of severe acute" exact="respiratory" post="syndrome coronavirus and middle east respiratory syndrome coronavirus fusionJ"/>
  <result pre="32.ColemanCMSiskJMMingoRMNelsonEAWhiteJMFriemanMBAbelson kinase inhibitors are potent inhibitors of severe acute respiratory" exact="syndrome" post="coronavirus and middle east respiratory syndrome coronavirus fusionJ Virol201690198924893310.1128/JVI.01429-1627466418"/>
  <result pre="inhibitors of severe acute respiratory syndrome coronavirus and middle east" exact="respiratory" post="syndrome coronavirus fusionJ Virol201690198924893310.1128/JVI.01429-1627466418 33.SunMLYangJMSunYPSuGHInhibitors of RAS might be"/>
  <result pre="of severe acute respiratory syndrome coronavirus and middle east respiratory" exact="syndrome" post="coronavirus fusionJ Virol201690198924893310.1128/JVI.01429-1627466418 33.SunMLYangJMSunYPSuGHInhibitors of RAS might be a"/>
 </snippets>
</snippetsTree>
